1781.TWO · H & L
Taiwan · RS rating 39 · As of 2026-10-08
| Price | 10.90 TWD |
|---|---|
| 1-day change | +9.8% |
| RS rating (overall / 1M / 3M / 12M) | 39 / 81 / 31 / 28 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 27 / 24 / 38 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | -68.4% |
| Sales growth Q/Q | -0.7% |
| Distance from 52-week high | +20.1% |
| Market cap (USD) | $14.8M |